Last $995.00 MXN
Change Today 0.00 / 0.00%
Volume 0.0
BAX* On Other Exchanges
Symbol
Exchange
New York
Mexico
As of 4:09 PM 07/17/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by BAXTER INTERNATIONAL INC (BAX*) in the last 6 months

Announced 07/9/14
AesRx, LLC
Merger/Acquisition

Baxter International Inc. (NYSE:BAX) acquired AesRx, LLC on July 9, 2014. Baxter made an initial payment to acquire AesRx and may make additional future payments based on specified development, regulatory and commercial milestones.


BAX*'s price was unchanged after the transaction was announced on 07/9/14.
Investor / Buyer
Baxter International Inc.
 
Announced 04/2/14
70.00M for Chatham Therapeutics LLC
Merger/Acquisition

Baxter International Inc. (NYSE:BAX) agreed to acquire membership interests of Chatham Therapeutics, LLC for $70 million on April 2, 2014. As per the terms of the deal, Baxter will make an initial payment of $70 million and may make additional payments in the future based on specified development, regulatory and commercial milestones. Following the acquisition, Chatham will maintain its licensing and development relationship with Asklepios BioPharmaceutical, Inc.


BAX*'s price was unchanged after the transaction was announced on 04/2/14.
Investor / Buyer
Baxter International Inc.
 
Announced 03/27/14
Baxter International Inc., Biopharmaceuticals Business
Spin-Off/Split-Off

The Board of Baxter International Inc. (NYSE:BAX) announced the spin-off of its biopharmaceuticals assets on March 27, 2014. Baxter International Inc. will form two separate publicly traded companies, one focused on biopharmaceuticals and the other focused on medical products, through a distribution to Baxter stockholders of shares in the new biopharmaceutical company. The biopharmaceuticals business reported revenues of $6 billion for the year ended December 31, 2013. ...
Read More


BAX*'s price was unchanged after the transaction was announced on 03/27/14.
Creditor / Lender
Baxter International Inc.
 
Announced 01/30/14
10.00M for Xenetic Biosciences, Inc.
Private Placement

Xenetic Biosciences, Inc. announced that it has received $10 million in equity funding from existing investor Baxter International Inc. on January 30, 2014.


BAX*'s price was unchanged after the transaction was announced on 01/30/14.
Investor / Buyer
Baxter International Inc.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAX*:MM $995.00 MXN 0.00

BAX* Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Astellas Pharma Inc ¥1,402 JPY +2.00
Covidien PLC $89.10 USD -0.19
Danone SA €55.99 EUR +0.01
Kimberly-Clark Corp $109.49 USD -0.01
Takeda Pharmaceutical Co Ltd ¥4,713 JPY +39.00
View Industry Companies
 

Industry Analysis

BAX*

Industry Average

Valuation BAX* Industry Range
Price/Earnings 21.6x
Price/Sales 2.5x
Price/Book 4.8x
Price/Cash Flow 21.4x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAXTER INTERNATIONAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.